Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

Publication Date: March 1, 2015
Last Updated: March 14, 2022

Recommendations

Detection of dysplasia on surveillance colonoscopy

1. When performing surveillance with white-light colonoscopy, high definition is recommended rather than standard definition.

(Low, Strong)
607

2. When performing surveillance with standard-definition colonoscopy, chromoendoscopy is recommended rather than white-light colonoscopy.

(Moderate, Strong)
607

3. When performing surveillance with high-definition colonoscopy, chromoendoscopy is suggested rather than white-light colonoscopy.

( Conditional , Low )
607

4. When performing surveillance with standard-definition colonoscopy, narrow-band imaging is not suggested in place of white-light colonoscopy.

( Conditional , Low )
607

5. When performing surveillance with high-definition colonoscopy, narrow-band imaging is not suggested in place of white-light colonoscopy.

( Conditional , Moderate )
607

6. When performing surveillance with image-enhanced high-definition colonoscopy, narrow-band imaging is not suggested in place of chromoendoscopy.

( Conditional , Moderate )
607

Management of dysplasia discovered on surveillance colonoscopy

7. After complete removal of endoscopically resectable polypoid dysplastic lesions, surveillance colonoscopy is recommended rather than colectomy.

( Strong , Very Low )
607

8. After complete removal of endoscopically resectable nonpolypoid dysplastic lesions, surveillance colonoscopy is suggested rather than colectomy.

( Conditional , Very Low )
607

9. For patients with endoscopically invisible dysplasia (confirmed by a GI pathologist) referral is suggested to an endoscopist with expertise in IBD surveillance using chromoendoscopy with high-definition colonoscopy.

( Conditional , Very Low )
607

Recommendation Grading

Overview

Title

Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

Authoring Organization

American Society for Gastrointestinal Endoscopy

Publication Month/Year

March 1, 2015

Last Updated Month/Year

January 10, 2024

Document Type

Consensus

External Publication Status

Published

Country of Publication

US

Inclusion Criteria

Female, Male, Adult, Older adult

Health Care Settings

Ambulatory, Hospital, Outpatient

Intended Users

Radiology technologist, nurse, nurse practitioner, physician, physician assistant

Scope

Assessment and screening, Diagnosis, Management

Diseases/Conditions (MeSH)

D015212 - Inflammatory Bowel Diseases

Keywords

inflammatory bowel disease, Crohn's disease, IBS, dysplasia

Source Citation

Laine, L., Kaltenbach, T., Barkun, A., McQuaid, K. R., Subramanian, V., Soetikno, R., … Yang, Y.-X. (2015). SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointestinal Endoscopy, 81(3), 489–501.e26. doi:10.1016/j.gie.2014.12.009

Methodology

Number of Source Documents
74
Literature Search Start Date
August 1, 2013
Literature Search End Date
September 24, 2013